• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    The Japanese journal of antibiotics

    The Japanese journal of antibiotics

    JournalISSN 0368-2781eISSN 2186-5477

    年发文量

    研究主题

    论文(4924)

    排序
    1Historical and Hygienic Aspects on Roles of Quality Requirements for Antibiotic Products in Japan: Part 5 - Introduction of Technology and Knowledge on Streptomycin Production from the United States of Americat.
    Morimasa Yagisawa, Patrick Foster,Tatsuo Kurokawa

    In order to investigate the roles of quality requirements for antibiotics products in Japan, from historical and hygienic aspects, we examined how technology and knowledge in the production and quality control of streptomycin were introduced from the United States of America. In this study, through detailed investigations and analyses, it was confirmed that the introduction of technology and knowledge on streptomycin was strongly supported by Brigadier General CRAWFORD SAms, the chief of the Public Health and Welfare Section (PHW) of the Supreme Commander for Allied Powers/General Headquarters, via the Ministry of Welfare in Japan. Dr. SELMAN WAKSMAN, the discoverer of streptomycin, along with scientists of Merck & Co., also helped Japanese industries extensively, via PHW, by providing the original streptomycin-producing strains and transferring expertise in streptomycin production. With the technology and knowledge being introduced from the USA, domestic production of streptomycin preparations increased very rapidly. As noted in our previous report, domestic production reached amounts enough to satisfy national demand within three years. Japanese people have a racial tendency to be highly susceptible to tuberculosis known as an incurable national disease. Thanks to streptomycin therapy, the tuberculosis mortality rate (per 100,000 population) had fallen dramatically within only five years from 187.2 in 1947 to 82.2 in 1952.

    2016引用:23
    引用
    AI阅读
    加入学术空间
    2[Carbapenem-resistant Enterobacteriaceae (CRE): a menace to the public and the mechanisms of antimicrobial resistance].
    Nakano R

    Dissemination of carbapenem-resistant Enterobacteriaceae (CRE) poses a considerable threat to public health. Infections caused by CRE have limited treatment options and have been associated with high mortality rates. This resistance is largely the consequence of acquisition of carbapenemase genes. The genotypes in the geographical areas were initially different, as the Japanese epidemic was related to the IMP type (Class B), whereas the US epidemic was related to the KPC type (Class A). Thus, clinical detection of carbapenemase producers remains difficult based on each genotypes has specific screening method. CRE has many problems: some carbapenemase producers were susceptible to the carbapenems and some CRE were not producing carbapenemase which is associated with porin loss or efflux pomp. This review describes the current situation of CRE. It would facilitate accurate detection of CRE and approaches to prevention and treatment.

    2016引用:23
    引用
    AI阅读
    加入学术空间
    3[New Therapeutic Strategies for Pulmonary Infection: the Potency of Immune Activation by Macrolides and Toll-like Receptor Agonist].
    Shigeki Nakamura,Koichi Izumikawa,Katsunori Yanagihara,Yoshitsugu Miyazaki,Hiroshi Mukae,Shigeru Kohno

    The balance of "Host-Pathogen-Antimicrobials" is crucial for the establishment of infectious diseases. Recently the ineffective cases, even though the appropriate antibiotics use, have been increasing since the several ineludible problems are rising, such as varied patient's background and the epidemic of the drug resistant pathogens, etc. Despite of the medical progression and the development of novel antimicrobials, the mortality of pneumonia has increased gradually and been the third cause of death in Japan. The conventional treatment depended on only bactericidal effect of antimicrobials faces a limit and the alternative strategies are required to overcome the current situation. This review addresses the potency of non-antibiotic antimicrobial agents as an alternative therapeutic strategy, especially focused on the activation of the innate host immunity induced by the macrolides and toll-like receptor agonist.

    2016引用:24
    引用
    AI阅读
    加入学术空间
    4[Current status and future prospects of the hepatitis B vaccine].
    Tatsuya Kanto
    2016引用:23
    引用
    AI阅读
    加入学术空间
    5[The Annual Changes in Antimicrobial Susceptibility Test Results of Pseudomonas Aeruginosa Isolates from the Kinki District].
    Saori Fukuda,Masaru Komatsu, Tatuya Nakamura,Takumi Jikimoto,Hisaaki Nishio,Katsutoshi Yamasaki,Kaori Satoh,Hirofumi Toda,Tamaki Orita,Noriyuki Sueyoshi,Machiko Kita,Isao Nishi,

    A study was conducted of the 1,225 Pseudomonas aeruginosa strains that were isolated at 20 medical institutions in the Kinki district between 2011 and 2013 to determine their antimicrobial susceptibility and to characterize the strains of multidrug-resistant Pseudomonas aeruginosa (MDRP) and the metallo-β-lactamase (MBL) -producing strains. The MIC50/MIC90 values (μg/mL) of the various antimicrobial agents were as follows: imipenem, 2/>8; meropenem, 1/>8; doripenem, 0.5/8; biapenem, 1/>8; tazobactam/piperacillin, 8/>64; piperacillin, 8/>64; sulbactam/cefoperazone, 8/64; cefepime, 4/16; cefozopran, 2/>16; aztreonam, 8/>16; amikacin, 4/16; levofloxacin, 1/>4; and ciprofloxacin, 0.25/>2. From the viewpoint of the annual changes in the susceptibility rates (according to the CLSI guidelines [M100-S22]), the susceptibility to tazobactam/piperacillin, piperacillin, cefepime, cefozopran and aztreonam decreased in 2013. On the other hand, two antimicrobial agents showed high susceptibility rates each year; amikacin (94.0-95.6%) showed the highest rate, followed by doripenem (80.3-82.6%). With the exception of amikacin, there were substantial inter-institutional differences in antimicrobial susceptibility. In comparison to the previous CLSI guidelines (M100-S21), the new CLSI guidelines (M100-S22) on the use of carbapenems and penicillins show that the MIC80 has been affected. The MDRP detection rates in 2011, 2012 and 2013 were 1.8% (8 strains), 1.8% (8 strains), and 2.8% (10 strains), respectively. The MBL detection rates were as follows: bla(VIM-2), 0.2% (1 strain) in 2011; bla(IMP-1), 0.9% (4 strains) in 2012, and 1.7% (6 strains, including bla(IMP-1) [3 strains], bla(IMP-2) [2 strains] and bla(VIM-2) [1 strain]) in 2013.

    2016引用:23
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 4924 篇论文

    高被引作者

    作者引用发文
    K Deguchi189983
    R Fujii181283
    S Fukayama171176
    T Motohiro166978
    H Meguro149970
    S Oda147966
    R Ishihara147766
    Koguchi M142863
    N. Yokota134360
    Y Sakata129259

    高产作者

    作者引用发文
    R Fujii181283
    K Deguchi189983
    T Motohiro166978
    S Fukayama171176
    H Meguro149970
    S Oda147966
    Yoshiaki Kumamoto48066
    R Ishihara147766
    Koguchi M142863
    N. Yokota134360

    相关期刊

    The Journal of respiratory diseases
    Chronic obstructive pulmonary diseases (Miami, Fla.)
    Asthma research and practice
    Open Respiratory Medicine Journal
    Journal of Association of Physicians of India
    Respiratory medical research
    Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation
    International Journal of Coronaviruses
    Black Sea Journal of Health Science
    Journal of Infectious Diseases and Epidemiology